Patient presents with [indication for Plavix use; e.g., history of myocardial infarction, recent stroke, peripheral artery disease] and is currently prescribed clopidogrel (Plavix) [dosage and frequency].  Assessment focuses on Plavix use, efficacy, and potential adverse effects.  Patient reports [patient-reported symptoms; e.g., no symptoms, easy bruising, epistaxis, fatigue, abdominal pain, black tarry stools]. Physical examination reveals [objective findings; e.g., no ecchymosis, petechiae present on lower extremities, pallor, abdominal tenderness].  Differential diagnoses include [relevant differential diagnoses; e.g., thrombocytopenia, gastrointestinal bleeding, drug-induced anemia, other causes of reported symptoms].  Laboratory results include [relevant lab values; e.g., complete blood count with platelet count, hemoglobin, hematocrit; coagulation studies including PT, INR, aPTT].  Current medication reconciliation includes [list of all current medications] to assess for potential drug interactions.  Patient education provided regarding signs and symptoms of serious adverse effects such as bleeding, including black tarry stools, hematuria, and unusual bruising.  Importance of medication adherence and regular follow-up appointments emphasized.  Treatment plan includes [plan modifications; e.g., continue Plavix as prescribed, reduce Plavix dosage, discontinue Plavix, consider alternative antiplatelet therapy, prescribe proton pump inhibitor for gastroprotection, referral to hematologist].  Follow-up scheduled in [timeframe] to monitor for efficacy and adverse events related to Plavix therapy.  Diagnosis: Plavix use and adverse effects, if applicable.  ICD-10 code: [appropriate ICD-10 code, e.g., T45.515A for adverse effect of clopidogrel].